DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Bulletin > Acta Medica Nagasakiensia > Volume 60, No. 2 >

The efficacy of magnesium in preventing renal dysfunction due to high-dose cisplatin for treatment of thoracic tumor


File Description SizeFormat
ActMed60_39.pdf886.41 kBAdobe PDFView/Open

Title: The efficacy of magnesium in preventing renal dysfunction due to high-dose cisplatin for treatment of thoracic tumor
Authors: Motoshima, Kohei / Nakamura, Yoichi / Shimada, Midori / Kitazaki, Takeshi / Senju, Hiroaki / Ogawara, Daiki / Takemoto, Shinnosuke / Mizoguchi, Kosuke / Sato, Shuntaro / Nakatomi, Katsumi / Fukuda, Minoru / Kohno, Shigeru
Issue Date: Jan-2016
Publisher: Nagasaki University School of Medicine / 長崎大学医学部
Citation: Acta medica Nagasakiensia, 60(2), pp.39-44; 2016
Abstract: Objective: Cisplatin is well known for producing severe adverse events, including renal dysfunction. To prevent renal dysfunction caused by cisplatin, routine magnesium supplementation is recommended. However, few reports exist about the efficacy of magnesium in preventing renal dysfunction. Therefore, the purpose of this study was to retrospectively survey the efficacy of magnesium in preventing renal dysfunction after administration of cisplatin. Methods: We evaluated patients who received first-line cisplatin-based chemotherapy from May 2008 to June 2013. Results: Data from 146 patients and a total of 394 treatments was analyzed. Elevation of serum creatinine was detected in 77 / 394 treatments (19.5%). Statistical significance was found between prevention of elevation of serum creatinine and magnesium supplementation. The other significant parameters were serum creatinine and eGFR levels before treatment and patient age. In multivariate analysis, magnesium and eGFR before treatment were statistically significant. Conclusions: The study results suggest that magnesium supplementation might reduce nephrotoxicity caused by cisplatin. The eGFR level before treatment might be an important factor associated with nephrotoxicity after cisplatin administration.
Keywords: cisplatin / renal dysfunction / magnesium / eGFR
URI: http://hdl.handle.net/10069/36167
ISSN: 00016055
Type: Departmental Bulletin Paper
Text Version: publisher
Appears in Collections:Volume 60, No. 2

Citable URI : http://hdl.handle.net/10069/36167

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace